Cannovum AG shares move Dec. 1st 2022 to primary market of Düsseldorf Stock Exchange

Cannovum AG, the first German fully licensed cannabis company on the stock exchange, will move on Dec. 1st 2022 from the Open Market to the "Primary Market" segment of the Düsseldorf Stock Exchange.

Cannovum AG shares move Dec. 1st 2022 to primary market of Düsseldorf Stock Exchange

Berlin, 28.11.22 - Cannovum AG, the first German fully licensed cannabis company on the stock exchange, will move on Dec. 1st 2022 from the Open Market to the "Primary Market" segment of the Düsseldorf Stock Exchange. With this move, the company commits to higher transparency standards and underlines its commitment to quality in its communication with investors.

"We are very pleased to be represented with our share in the primary market," says Pia Marten, board member and co-founder of Cannovum AG. "The change is an important step for us as a growth company. This demonstrates our claim as a market leader in the upcoming legal cannabis segment. This emerging market will account for well over 8 billion euros in sales per year in Germany alone."

 

About Cannovum:

 

Cannovum AG is the first German fully licensed cannabis company to be listed on the stock exchange. The shares are traded on the Düsseldorf, Munich, Berlin, Hamburg and gettex stock exchanges.Through its subsidiary Cannovum Health eG, it is a fully licensed pharmaceutical wholesaler, importer, and manufacturer of high-quality medicalcannabis products based in Berlin. Cannovum AG is ready for the legalization of cannabis and well prepared: for sales through pharmacies as well as through licensed specialty stores and online shipping. Cannovum AG is already a market leader in the medical cannabis sector. Currently, the company is active in the importation of high-quality cannabinoid precursors, medical-scientific education and nationwide distribution for a simplified and equitable access to cannabis-based therapies.

 

Contact:

Klaus Madzia, IR & PR, Cannovum AG

Phone +49 30 3982 163 62, klaus.madzia@cannovum.com

Read more
Download pdf

Mehr News

Other
December 2022

Cannovum AG share enters Xetra trading

The share of Cannovum AG has been included in trading on the Xetra and Frankfurt Stock Exchange. This means that Cannovum AG is now represented on Germany's largest and most important stock exchange.

Other
December 2022

Cannovum AG enters into supply agreement for medical cannabis with WEECO

Cannovum AG enters into a partnership with WEECO Pharma GmbH. As of today, Cannovum will include WEECO's products in its portfolio, taking another important step towards becoming a full-service cannabis provider.

Other
November 2022

Cannovum AG expands management board

Cannovum AG expands its Management Board. The new board position of the first German fully licensed cannabis company on the stock exchange will be taken over by Klaus Madzia as of 25.11.2022.